As prescription drug costs continue to squeeze state budgets, a group of state health policy makers is offering some novel – and also some familiar – suggestions for coping. These include regulating the pharmaceutical industry as a utility, allowing states to operate as pharmacy benefit managers and waiving some provisions of the Medicaid program. In […]
A United Nations panel recently released a series of disastrous policy recommendations designed to increase access to medicines in developing countries. The panel ignored obvious solutions to help the one in three people in developing nations who lack regular access to medicines. Secretary General Ban Ki-Moon originally tasked the UN High-Level Panel on Access to […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AMBISOME (amphotericin b) Astellas Patent number: 5,965,156 Expiration Date: Oct 12, 2016 SPECTRACEF (cefditoren pivoxil) Vansen Pharma Patent number: 5,958,915 Expiration Date: Oct 14, 2016 VARITHENA […]
Approved Drug Products With Therapeutic Equivalance Evaluations In addition to its deep database of global drug and patent information, DrugPatentWatch also has archives of the Food and Drug Administration (FDA) Orange Book, or Approved Drug Products With Therapeutic Equivalence Evaluationscatalogs. The Orange Book identifies drug products approved on the basis of safety and effectiveness by […]
This is a guest post from Jeriann Watkins at . Do you have a response to Jeriann’s post? Respond in the comments section below. The field of microbiotics has received a surge of public attention in the past few years. This is for two related but separate reasons. The first is the advancement of technology […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer Ingelheim Patent number: 6,176,442 Expiration Date: Oct 4, 2016 STRIVERDI RESPIMAT (olodaterol hydrochloride) Boehringer Ingelheim Patent number: 7,104,470 Expiration Date: Oct […]
This is a guest post from Edward Simpson, a seasoned calibration and technical engineer. Do you have a response to Edward’s post? Respond in the comments section below. Process validation is a crucial component of cGMP (current Good Manufacturing Practice) in industries concerned with public health and safety, such as pharma, bio-pharma and biotech. What […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. TRIZIVIR (abacavir sulfate; lamivudine; zidovudine) Viiv Hlthcare Patent number: 6,417,191 Expiration Date: Sep 28, 2016 TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine) Viiv Hlthcare Patent number: 6,417,191 […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. JENTADUETO XR (linagliptin; metformin hydrochloride) Boehringer Ingelheim Patent number: 6,340,475 Expiration Date: Sep 19, 2016 JENTADUETO XR (linagliptin; metformin hydrochloride) Boehringer Ingelheim Patent number: 6,635,280 Expiration […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. KYTRIL (granisetron hydrochloride) Roche Patent number: 5,952,340 Expiration Date: Sep 14, 2016 AZILECT (rasagiline mesylate) Teva Patent number: 6,126,968 Expiration Date: Sep 18, 2016 DrugPatentWatch provides […]